Immediate Impact
1 by Nobel laureates 54 standout
Citing Papers
The hallmarks of cancer immune evasion
2024 Standout
Paradigm Shift: A Comprehensive Review of Ovarian Cancer Management in an Era of Advancements
2024 Standout
Works of S.T. Kim being referenced
Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced/metastatic melanoma who have failed prior anti-PD-1 therapy
2021
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| S.T. Kim | 206 | 273 | 97 | 106 | 19 | 391 | |
| Darren M. Kocs | 135 | 216 | 107 | 145 | 16 | 397 | |
| James D. Peyton | 145 | 199 | 60 | 172 | 27 | 359 | |
| Macdonald Js | 119 | 247 | 67 | 80 | 20 | 434 | |
| Jong Ho Chun | 195 | 202 | 114 | 128 | 21 | 411 | |
| See‐Chun Phan | 247 | 297 | 66 | 89 | 17 | 427 | |
| Marina Kem | 111 | 206 | 59 | 143 | 18 | 391 | |
| Quanren Wang | 163 | 304 | 96 | 75 | 25 | 421 | |
| Fa-Chyi Lee | 151 | 186 | 50 | 120 | 24 | 368 | |
| Ju-Hee Bang | 104 | 244 | 66 | 126 | 17 | 375 | |
| Giulia Grizzi | 177 | 255 | 37 | 81 | 24 | 354 |
All Works
Loading papers...